Suma M. Krishnan
Founder bei KRYSTAL BIOTECH, INC.
Vermögen: 276 Mio $ am 31.03.2024
Profil
Suma M.
Krishnan founded Krystal Biotech, Inc. in 2016, where she is working as Director, President-Research & Development from 2022.
Ms. Krishnan also currently works at Jeune Aesthetics, Inc., as Director.
Ms. Krishnan also formerly worked at Shire Pharmaceuticals, Inc., as Director-Regulatory Affairs from 2000 to 2002, Pfizer Inc., as Senior Manager-Projects, New River Pharmaceuticals, Inc., as Senior Vice President-Product Development from 2002 to 2007, Precigen, Inc., as Senior VP-Regulatory Affairs & Head-Therapeutics from 2012 to 2016, Pinnacle Pharmaceuticals LLC, as Senior Vice President-Product Development from 2010 to 2011, Janssen Pharmaceutical KK, as Discovery Scientist, and The Weinberg Group, Inc., as Consultant in 1997.
Ms. Krishnan received her graduate degree from Villanova University, Masters Business Admin degree from Institute of Management, Development & Research, and undergraduate degree from Fergusson College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KRYSTAL BIOTECH, INC.
5,48% | 11.03.2024 | 1 550 882 ( 5,48% ) | 276 Mio $ | 31.03.2024 |
Aktive Positionen von Suma M. Krishnan
| Unternehmen | Position | Beginn |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Founder | 15.04.2016 |
Jeune Aesthetics, Inc.
 Jeune Aesthetics, Inc. BiotechnologyHealth Technology Jeune Aesthetics, Inc. is a biotechnology company. The private company is based in Pittsburgh, PA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Suma M. Krishnan
| Unternehmen | Position | Ende |
|---|---|---|
| PRECIGEN, INC. | General Counsel | 01.01.2016 |
Pinnacle Pharmaceuticals LLC
 Pinnacle Pharmaceuticals LLC BiotechnologyHealth Technology Pinnacle Pharmaceuticals LLC developed a novel compound effective against multi-drug-resistant bacterial strains. The company was headquartered in Radford, VA. | Corporate Officer/Principal | 01.01.2011 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01.04.2007 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | General Counsel | 01.08.2002 |
The Weinberg Group, Inc.
 The Weinberg Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Weinberg Group, Inc. provides regulatory and compliance services. Its services include medical devices, drugs and biotech, anda submissions, and quality and compliance. The company was founded by Myron S. Weinberg in 1983 and is headquartered in Washington, DC. | Corporate Officer/Principal | 01.12.1997 |
Ausbildung von Suma M. Krishnan
| Villanova University | Graduate Degree |
| Institute of Management, Development & Research | Masters Business Admin |
| Fergusson College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| PRECIGEN, INC. | Health Technology |
| KRYSTAL BIOTECH, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
Pinnacle Pharmaceuticals LLC
Pinnacle Pharmaceuticals LLC BiotechnologyHealth Technology Pinnacle Pharmaceuticals LLC developed a novel compound effective against multi-drug-resistant bacterial strains. The company was headquartered in Radford, VA. | Health Technology |
Janssen Pharmaceutical KK
 Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals KK develops, manufactures, and markets prescription pharmaceutical products. The company was founded in 1978 and is located in Tokyo, Japan. | Health Technology |
The Weinberg Group, Inc.
The Weinberg Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Weinberg Group, Inc. provides regulatory and compliance services. Its services include medical devices, drugs and biotech, anda submissions, and quality and compliance. The company was founded by Myron S. Weinberg in 1983 and is headquartered in Washington, DC. | Commercial Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Jeune Aesthetics, Inc. is a biotechnology company. The private company is based in Pittsburgh, PA. | Health Technology |
